Goldman Sachs
IDYA icon

Goldman Sachs’s IDEAYA Biosciences IDYA Stock Holding History

Goldman Sachs’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Buy
+178,000
New +$5.97M ﹤0.01% 3525

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Goldman Sachs's IDYA Position: Q1 2026 in Review

Goldman Sachs reduced its IDEAYA Biosciences (IDYA) stake by 6.5% in Q1 2026, selling an estimated $3.87M and leaving 1,655,617 shares worth $55.2M. The position accounts for 0.01% of the portfolio, ranked #1500.

Goldman Sachs first reported a position in IDYA in Q2 2019 and has held it in 28 quarters since. The position peaked at $61.2M in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Goldman Sachs held 1,655,617 shares of IDEAYA Biosciences worth $55.2M as of Q1 2026.
  • Goldman Sachs sold 115,249 IDEAYA Biosciences shares in Q1 2026, an estimated $3.87M.
  • IDEAYA Biosciences made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1500 holding.
  • Goldman Sachs first reported a position in IDEAYA Biosciences in Q2 2019 and has held it in 28 quarters since.
  • Goldman Sachs's IDEAYA Biosciences position peaked at $61.2M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.